| 标题 |
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Bruce E. Sands; Peter M. Irving; Timothy Hoops; James Izanec; Long-Long Gao; et al 出版日期:2022-06-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)